PhD Monitor
/Detail
Biotechnology and Bioprocess Engineering● OpenPreview

PhD Position in Bioproduction of Genetically Modified Monocytes

Develop robust, GMP-compliant bioprocessing methods for the production of therapeutic monocytes to treat triple-negative breast cancer.

Best for:Best for candidates with a background in bioprocess engineering, cell therapy, or biotechnology interested in GMP-compliant manufacturing.

Laboratoire Réactions et Génie des Procédés (UMR CNRS 7274) · Vandoeuvre-lès-Nancy, France · R1 · First-stage researcher
More professors at Laboratoire Réactions et Génie des Procédés (UMR CNRS 7274)
BioproductionCell TherapyGMP ManufacturingMonocyte EngineeringBioreactor OptimizationTriple-Negative Breast Cancer
Deadline
Oct 29, 2026
15 days
Funding
Salaried
€2.3k/mo
Start date
2026-12-06
Fixed-term
Location
Vandoeuvre-lès-Nancy
France

Overview

This PhD project is part of the 'Mono-Chem' PEPR Biotherapies Bioproductions initiative, focusing on the development of genetically modified human monocytes as therapeutic vectors for triple-negative breast cancer. The successful candidate will work within the MTInov integrator, a collaboration between the CHRU of Nancy and the Laboratory of Reactions and Chemical Engineering (LRGP). The research involves optimizing cell isolation and transduction processes under Good Manufacturing Practice (GMP) conditions using automated systems like Sepax C-Pro and CliniMACS Prodigy. The goal is to establish scalable, robust protocols that ensure high cell purity, viability, and therapeutic efficacy for clinical transfer.

BioprocessingGMPCell TherapyMonocytesTransductionBioreactorClinical Transfer

What you'll do

  • Develop and optimize scientific methodologies for the isolation and transduction of monocytes under GMP conditions.
  • Compare and evaluate different automated isolation methods using the CliniMACS Prodigy system.
  • Optimize transduction protocols using lentiviral vectors in bioreactors such as G-Rex or CentriCult.
  • Ensure all developed processes meet strict quality specifications for purity, viability, and modification rates.
  • Perform functional qualification tests on modified monocytes and macrophages.
  • Collaborate with multidisciplinary teams to facilitate the clinical transfer of therapeutic cell products.

Requirements

Degree required: Master's degree in Biotechnology, Bioprocess Engineering, or a related field.

Degree offered: PhD

Language: French or English proficiency suitable for research and technical documentation.

Instruction: French/English

Required skills
  • Experience with cell culture and bioreactor systems.
  • Knowledge of Good Manufacturing Practices (GMP) in a clinical or laboratory setting.
  • Proficiency in cell isolation and characterization techniques.
  • Ability to work in controlled production environments.
Nice to have
Experience with automated cell processing systems like CliniMACS Prodigy.Background in immunology or cancer research.Experience with lentiviral transduction protocols.
Eligibility
  • Must hold a Master's degree or equivalent.

Funding & terms

Type
Salaried
Amount
€2.3k/mo
Duration
3 years
Programme
PEPR Biothérapies Bioproductions
CNRS

How to apply

Deadline: 2026-10-29

Interested candidates should apply through the official CNRS employment portal. Ensure all required documents are uploaded before the deadline.

Documents required
  • CV
  • Cover letter
↗Apply on site
Lab
Laboratoire Réactions et Génie des Procédés (LRGP)
Laboratoire Réactions et Génie des Procédés (UMR CNRS 7274)
PEPR Biothérapies BioproductionsFrance
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
15 days until the deadline — open this position on its website.